Compass Pathways Plc Stock Performance
| CMPS Stock | USD 4.45 0.30 7.23% |
The firm shows a Beta (market volatility) of -0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Compass Pathways are expected to decrease at a much lower rate. During the bear market, Compass Pathways is likely to outperform the market. At this point, Compass Pathways Plc has a negative expected return of -0.36%. Please make sure to confirm Compass Pathways' value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Compass Pathways Plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Compass Pathways Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 7.23 | Five Day Return 12.94 | Year To Date Return 7.23 | Ten Year Return (84.66) | All Time Return (84.66) |
1 | Disposition of 17203 shares by Malievskaia Ekaterina of Compass Pathways at 10.8049 subject to Rule 16b-3 | 10/25/2024 |
2 | COMPASS Pathways plc Short Interest Down 9.1 percent in October | 10/31/2024 |
3 | COMPASS Pathways plc Q3 2024 Earnings Call Transcript | 11/01/2024 |
4 | FDA Endorses CaaMTechs Psilocin Drug Development For Depression Treatment | 11/14/2024 |
5 | Citadel Advisors LLC Expands Stake in Compass Pathways PLC | 11/15/2024 |
6 | Hercules Capital Is Its 10 percent Yield As Strong As It Looks | 11/21/2024 |
7 | COMPASS Pathways plc has caught the attention of institutional investors who hold a sizeable 29 percent stake | 11/25/2024 |
8 | Ikarian Capital LLC Sells 100,000 Shares of COMPASS Pathways plc | 12/03/2024 |
9 | Compass Pathways SWOT analysis psilocybin stock faces trials and trillion-dollar potential | 12/18/2024 |
10 | Disposition of 23881 shares by George Goldsmith of Compass Pathways at 8.5289 subject to Rule 16b-3 | 12/24/2024 |
| Begin Period Cash Flow | 143.4 M | |
| Free Cash Flow | -97.4 M |
Compass |
Compass Pathways Relative Risk vs. Return Landscape
If you would invest 603.00 in Compass Pathways Plc on October 8, 2024 and sell it today you would lose (158.00) from holding Compass Pathways Plc or give up 26.2% of portfolio value over 90 days. Compass Pathways Plc is currently does not generate positive expected returns and assumes 4.949% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Compass, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Compass Pathways Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compass Pathways' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Compass Pathways Plc, and traders can use it to determine the average amount a Compass Pathways' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0733
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CMPS |
Estimated Market Risk
| 4.95 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Compass Pathways is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compass Pathways by adding Compass Pathways to a well-diversified portfolio.
Compass Pathways Fundamentals Growth
Compass Stock prices reflect investors' perceptions of the future prospects and financial health of Compass Pathways, and Compass Pathways fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compass Stock performance.
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 130.07 M | ||||
| Shares Outstanding | 68.42 M | ||||
| Price To Book | 1.58 X | ||||
| EBITDA | (123.8 M) | ||||
| Net Income | (118.46 M) | ||||
| Cash And Equivalents | 207.18 M | ||||
| Cash Per Share | 4.87 X | ||||
| Total Debt | 33.05 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 17.53 X | ||||
| Book Value Per Share | 2.82 X | ||||
| Cash Flow From Operations | (97.38 M) | ||||
| Earnings Per Share | (2.18) X | ||||
| Market Capitalization | 304.47 M | ||||
| Total Asset | 275.99 M | ||||
| Retained Earnings | (379.61 M) | ||||
| Working Capital | 241.69 M | ||||
About Compass Pathways Performance
Assessing Compass Pathways' fundamental ratios provides investors with valuable insights into Compass Pathways' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Compass Pathways is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.39) | (0.41) | |
| Return On Capital Employed | (0.48) | (0.50) | |
| Return On Assets | (0.39) | (0.41) | |
| Return On Equity | (0.60) | (0.57) |
Things to note about Compass Pathways Plc performance evaluation
Checking the ongoing alerts about Compass Pathways for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compass Pathways Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Compass Pathways Plc generated a negative expected return over the last 90 days | |
| Compass Pathways Plc has high historical volatility and very poor performance | |
| Net Loss for the year was (118.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Compass Pathways Plc currently holds about 207.18 M in cash with (97.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Compass Pathways Plc has a poor financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Compass Pathways SWOT analysis psilocybin stock faces trials and trillion-dollar potential |
- Analyzing Compass Pathways' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compass Pathways' stock is overvalued or undervalued compared to its peers.
- Examining Compass Pathways' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Compass Pathways' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compass Pathways' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Compass Pathways' stock. These opinions can provide insight into Compass Pathways' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.